This site may require a log-in in the near future. We are constantly being swamped by AI agents. If they continue to take down the site, we will be changing to requiring logins to access any item.

🍽️ fenbendazole,(prescription)

AI Engines For more Details: PerplexityKagi LabsYou

  1. Antiparasitic Effects: Fenbendazole is highly effective against a wide range of parasitic infections in animals, including nematodes (roundworms), cestodes (tapeworms), and trematodes (flukes). It works by disrupting the microtubule structure in the parasites, leading to paralysis and death.

  2. Treatment of Intestinal Parasites: Fenbendazole is commonly used to treat gastrointestinal parasites such as roundworms, hookworms, whipworms, and tapeworms in dogs, cats, horses, livestock, and other animals. It helps eliminate the parasites from the intestines, thereby reducing symptoms such as diarrhea, vomiting, weight loss, and abdominal discomfort.

  3. Liver Fluke Infections: Fenbendazole is effective against liver fluke infections, including Fasciola hepatica and Fasciola gigantica, which can affect livestock such as cattle, sheep, and goats. By killing the immature and adult flukes, fenbendazole helps control the spread of these parasitic infections and prevent liver damage in animals.

  4. Lungworm Infections: Fenbendazole is also used to treat lungworm infections in animals, including Metastrongylus spp. in pigs and Dictyocaulus spp. in cattle, sheep, and goats. It helps eliminate the lungworm larvae and adults from the respiratory tract, reducing respiratory symptoms and improving lung function.

  5. Protozoal Infections: In addition to parasitic worms, fenbendazole may have activity against certain protozoal infections in animals, although its efficacy varies depending on the specific parasite species. It is sometimes used off-label for the treatment of protozoal infections such as Giardia and coccidiosis in animals.

  6. Potential Anticancer Effects: There is growing interest in the potential anticancer effects of fenbendazole in humans. Some studies and anecdotal reports suggest that fenbendazole, when used in combination with other drugs or supplements, may inhibit cancer cell growth, induce apoptosis (cell death), and suppress tumor progression. However, more research is needed to fully understand its mechanisms of action and efficacy in cancer treatment.

  7. Safety Considerations: Fenbendazole is generally well-tolerated in animals when used at recommended doses. However, adverse effects such as vomiting, diarrhea, lethargy, and allergic reactions may occur in some cases. It is important to follow dosage instructions carefully and consult a veterinarian before administering fenbendazole to animals, especially pregnant or lactating animals and those with pre-existing health conditions.

  8. Drug Interactions: Fenbendazole may interact with certain medications or supplements in animals, potentially affecting their efficacy or safety. It is important to inform the veterinarian about all medications, supplements, and health conditions of the animal before starting fenbendazole treatment.

  9. Resistance: Prolonged or repeated use of fenbendazole in animals may lead to the development of drug-resistant parasites. To minimize the risk of resistance, fenbendazole should be used judiciously and as part of a comprehensive parasite control program that includes proper hygiene, sanitation, and rotation of anthelmintic drugs.

;

Check for interactions on Supp.AI   |   πŸ“š PubMed Citations

βš—οΈ Compensation for antibiotic usage

Data Contradictions β€” Limits of Certainity

Impacted of fenbendazole,(prescription) On Probiotics

Rank Probiotic Impact
genus Bifidobacterium Reduces
species Akkermansia muciniphila Reduces
species Bacteroides uniformis Reduces
species Bifidobacterium adolescentis Reduces
species Bifidobacterium longum Reduces
species Escherichia coli Reduces
species Lactobacillus acidophilus Reduces
species Lactobacillus crispatus Reduces
species Lactobacillus gasseri Reduces
species Lactobacillus helveticus Reduces
species Lactobacillus jensenii Reduces
species Lactobacillus johnsonii Reduces
species Lactobacillus kefiranofaciens Reduces
species Parabacteroides distasonis Reduces
subspecies Bifidobacterium longum subsp. infantis Reduces
subspecies Bifidobacterium longum subsp. longum Reduces

Bacteria Impacted by fenbendazole,(prescription)

We extend modifiers to include items that changes the parent and child taxa. I.e. for a species, that would be the genus that is belongs to and the strains in the species.

πŸ§™?

πŸ““ Direct Citations πŸ‘ͺπŸ‘Ά Indirect Citations Taxonomy Rank Effect
0 1 Terrabacteria group clade Decreases
0 1 PVC group clade Increases
0 1 Actinomycetes class Decreases
0 1 Nitriliruptoria class Decreases
0 1 Coriobacteriia class Decreases
0 1 Acidimicrobiia class Decreases
0 1 Rubrobacteria class Decreases
0 1 Thermoleophilia class Decreases
0 1 Opitutia class Increases
0 1 Methylacidiphilae class Increases
0 1 Spartobacteria class Increases
0 1 Terrimicrobiia class Increases
0 1 Verrucomicrobiia class Increases
0 1 Akkermansiaceae family Decreases
0 1 Lactobacillaceae family Decreases
0 1 Escherichia genus Decreases
0 1 Dorea genus Decreases
0 1 Roseburia genus Decreases
1 0 Lactobacillus genus Decreases
0 1 Parabacteroides genus Decreases
0 1 Agathobacter genus Decreases
0 1 Bacteroides genus Decreases
0 1 Bifidobacterium genus Decreases
0 1 Clostridioides genus Decreases
0 1 Coprococcus genus Decreases
0 1 Eggerthella genus Decreases
0 1 Lachnospira genus Decreases
0 1 Mediterraneibacter genus Decreases
0 1 Phocaeicola genus Decreases
0 1 Streptococcus genus Decreases
1 0 Akkermansia genus Decreases
0 1 Clostridium genus Decreases
0 1 Segatella genus Decreases
0 1 Blautia genus Decreases
0 1 Escherichia coli O25:H16 no rank Decreases
0 1 Clostridium perfringens A no rank Decreases
0 1 Clostridium perfringens C no rank Decreases
0 1 Clostridium perfringens CPE no rank Decreases
0 1 environmental samples no rank Decreases
0 1 environmental samples no rank Decreases
0 1 Escherichia coli O145:H34 no rank Decreases
0 1 Escherichia coli O16:H48 no rank Decreases
0 1 unclassified Actinomycetota no rank Decreases
0 1 unclassified Akkermansia no rank Decreases
0 1 unclassified Lactobacillus no rank Decreases
0 1 Clostridium perfringens D no rank Decreases
0 1 Escherichia coli O141:H4 no rank Decreases
0 1 Clostridium perfringens B no rank Decreases
0 1 Escherichia coli O139:H1 no rank Decreases
0 1 Clostridium perfringens E no rank Decreases
0 1 Escherichia coli O80:H26 no rank Decreases
0 1 Escherichia coli O158:H23 no rank Decreases
0 1 Escherichia coli O84:H7 no rank Decreases
0 1 Escherichia coli O2:K1:H4 no rank Decreases
0 1 Escherichia coli O2:K1:H7 no rank Decreases
0 1 Escherichia coli O78:H51 no rank Decreases
0 1 Escherichia coli O18ac:H14 no rank Decreases
0 1 Escherichia coli O85:H1 no rank Decreases
0 1 Escherichia coli O7:H15 no rank Decreases
0 1 Escherichia coli O68:H12 no rank Decreases
0 1 Escherichia coli O55:H7 no rank Decreases
0 1 Escherichia coli O1:K1:H7 no rank Decreases
0 1 Escherichia coli O15:H12 no rank Decreases
0 1 Escherichia coli O170:H18 no rank Decreases
0 1 Escherichia coli O155:H21 no rank Decreases
0 1 Escherichia coli O19:H7 no rank Decreases
0 1 Escherichia coli O2:K1:H5 no rank Decreases
0 1 Escherichia coli O20:H12 no rank Decreases
0 1 environmental samples no rank Increases
0 1 unclassified Verrucomicrobiota no rank Increases
0 1 Verrucomicrobiota incertae sedis no rank Increases
1 0 Actinomycetota phylum Decreases
1 0 Verrucomicrobiota phylum Increases
0 1 Escherichia coli O111 serogroup Decreases
0 1 Escherichia coli O121 serogroup Decreases
0 1 Escherichia coli O155 serogroup Decreases
0 1 Escherichia coli O177 serogroup Decreases
0 1 Escherichia coli O26 serogroup Decreases
0 1 Escherichia coli O3 serogroup Decreases
0 1 Escherichia coli O5 serogroup Decreases
0 1 Escherichia coli O86 serogroup Decreases
0 1 Escherichia coli O91 serogroup Decreases
0 1 Escherichia coli O103 serogroup Decreases
0 1 Escherichia coli O78 serogroup Decreases
0 1 Escherichia coli O43 serogroup Decreases
0 1 Escherichia coli O119 serogroup Decreases
0 1 Escherichia coli O157 serogroup Decreases
0 1 Escherichia coli O145 serogroup Decreases
0 1 Escherichia coli O1:HNT serotype Decreases
0 1 Escherichia coli O10:K5(L):H4 serotype Decreases
0 1 Escherichia coli O103:H11 serotype Decreases
0 1 Escherichia coli O103:H25 serotype Decreases
0 1 Escherichia coli O104:H21 serotype Decreases
0 1 Escherichia coli O111:H11 serotype Decreases
0 1 Escherichia coli O111:H8 serotype Decreases
0 1 Escherichia coli O112ac:H19 serotype Decreases
0 1 Escherichia coli O114:H49 serotype Decreases
0 1 Escherichia coli O118:H16 serotype Decreases
0 1 Escherichia coli O121:H7 serotype Decreases
0 1 Escherichia coli O123:H11 serotype Decreases
0 1 Escherichia coli O127:H27 serotype Decreases
0 1 Escherichia coli O127:H6 serotype Decreases
0 1 Escherichia coli O128:H2 serotype Decreases
0 1 Escherichia coli O128ac:H12 serotype Decreases
0 1 Escherichia coli O145:H25 serotype Decreases
0 1 Escherichia coli O145:NM serotype Decreases
0 1 Escherichia coli O146:H21 serotype Decreases
0 1 Escherichia coli O153:H2 serotype Decreases
0 1 Escherichia coli O156:H25 serotype Decreases
0 1 Escherichia coli O157:H43 serotype Decreases
0 1 Escherichia coli O157:NM serotype Decreases
0 1 Escherichia coli O165:H25 serotype Decreases
0 1 Escherichia coli O174:H2 serotype Decreases
0 1 Escherichia coli O174:H21 serotype Decreases
0 1 Escherichia coli O174:H8 serotype Decreases
0 1 Escherichia coli O176:H45 serotype Decreases
0 1 Escherichia coli O177:NM serotype Decreases
0 1 Escherichia coli O26:H1 serotype Decreases
0 1 Escherichia coli O28ac:NM serotype Decreases
0 1 Escherichia coli O29:H4 serotype Decreases
0 1 Escherichia coli O32:H37 serotype Decreases
0 1 Escherichia coli O6:H16:CFA/II serotype Decreases
0 1 Escherichia coli O69:H11 serotype Decreases
0 1 Escherichia coli O78:H12 serotype Decreases
0 1 Escherichia coli O79:H7 serotype Decreases
0 1 Escherichia coli O81:NM serotype Decreases
0 1 Escherichia coli O86:H34 serotype Decreases
0 1 Escherichia coli O91:H14 serotype Decreases
0 1 Escherichia coli O91:NM serotype Decreases
0 1 Escherichia coli ONT:H33 serotype Decreases
0 1 Escherichia coli O100:H21 serotype Decreases
0 1 Escherichia coli O121:H19 serotype Decreases
0 1 Escherichia coli O157:H7 serotype Decreases
0 1 Escherichia coli O16:H6 serotype Decreases
0 1 Escherichia coli O89m:H9 serotype Decreases
0 1 Escherichia coli O111:H- serotype Decreases
0 1 Escherichia coli O113:H21 serotype Decreases
0 1 Escherichia coli H20 serotype Decreases
0 1 Escherichia coli O150:H6 serotype Decreases
0 1 Escherichia coli O111:NM serotype Decreases
0 1 Escherichia coli O112ab:H8 serotype Decreases
0 1 Escherichia coli O99:H6 serotype Decreases
0 1 Escherichia coli O26:H11 serotype Decreases
0 1 Escherichia coli O145:H28 serotype Decreases
0 1 Escherichia coli O126:H45 serotype Decreases
0 1 Escherichia coli O2:H6 serotype Decreases
0 1 Escherichia coli O7:H4 serotype Decreases
0 1 Escherichia coli O1:H42 serotype Decreases
0 1 Escherichia coli O25:NM serotype Decreases
0 1 Escherichia coli O25:H1 serotype Decreases
0 1 Escherichia coli O7:K1 serotype Decreases
0 1 Escherichia coli O125ac:K+:H10 serotype Decreases
0 1 Escherichia coli O6:K2:H1 serotype Decreases
0 1 Escherichia coli O152:H23 serotype Decreases
0 1 Escherichia coli O15:H18 serotype Decreases
0 1 Escherichia coli O39:NM serotype Decreases
0 1 Escherichia coli O44:H18 serotype Decreases
0 1 Escherichia coli O2:K2:H1 serotype Decreases
0 1 Escherichia coli O8:H8 serotype Decreases
0 1 Escherichia coli O89m:H10 serotype Decreases
0 1 Escherichia coli O10:H32 serotype Decreases
0 1 Escherichia coli O6:H16 serotype Decreases
0 1 Escherichia coli O157:H- serotype Decreases
0 1 Escherichia coli O45:H2 serotype Decreases
0 1 Escherichia coli O103:H2 serotype Decreases
0 1 Escherichia coli O167:H26 serotype Decreases
0 1 Escherichia coli O104:H4 serotype Decreases
0 1 Escherichia coli O83:H1 serotype Decreases
0 1 Escherichia coli O9:H10 serotype Decreases
0 1 Escherichia coli O78:H4 serotype Decreases
0 1 Escherichia coli O139:H28 serotype Decreases
1 0 [Ruminococcus] torques species Decreases
1 0 Bacteroides thetaiotaomicron species Decreases
1 0 Blautia obeum species Decreases
1 0 Clostridium perfringens species Decreases
1 0 Roseburia intestinalis species Decreases
1 0 Streptococcus salivarius species Decreases
1 0 Coprococcus comes species Decreases
1 0 Lachnospira eligens species Decreases
1 0 Bacteroides fragilis species Decreases
1 0 Akkermansia muciniphila species Decreases
1 0 Dorea formicigenerans species Decreases
1 0 Bifidobacterium adolescentis species Decreases
0 1 Lactobacillus delbrueckii species Decreases
1 0 Phocaeicola vulgatus species Decreases
0 1 [Lactobacillus] rogosae species Decreases
0 1 Akkermansia massiliensis species Decreases
0 1 ATCC 15434 species Decreases
0 1 Candidatus Akkermansia intestinavium species Decreases
0 1 Lactobacillus alvei species Decreases
0 1 Lactobacillus animata species Decreases
0 1 Lactobacillus apis species Decreases
0 1 Lactobacillus bombicola species Decreases
0 1 Lactobacillus brevisimilis species Decreases
0 1 Lactobacillus equicursoris species Decreases
0 1 Lactobacillus faeni species Decreases
0 1 Lactobacillus fornicalis species Decreases
0 1 Lactobacillus gallinarum species Decreases
0 1 Lactobacillus gigeriorum species Decreases
0 1 Lactobacillus guizhouensis species Decreases
0 1 Lactobacillus hamsteri species Decreases
0 1 Lactobacillus helsingborgensis species Decreases
0 1 Lactobacillus hominis species Decreases
0 1 Lactobacillus intermedius species Decreases
0 1 Lactobacillus japonicus species Decreases
0 1 Lactobacillus kalixensis species Decreases
0 1 Lactobacillus kitasatonis species Decreases
0 1 Lactobacillus kullabergensis species Decreases
0 1 Lactobacillus leichmannii species Decreases
0 1 Lactobacillus letivazi species Decreases
0 1 Lactobacillus mulieris species Decreases
0 1 Lactobacillus panisapium species Decreases
0 1 Lactobacillus pasteurii species Decreases
0 1 Lactobacillus psittaci species Decreases
0 1 Lactobacillus rodentium species Decreases
0 1 Lactobacillus selangorensis species Decreases
0 1 Lactobacillus sp. 7_1_47FAA species Decreases
0 1 Lactobacillus sp. MYMRS/TEN2 species Decreases
0 1 Lactobacillus terrae species Decreases
1 0 Parabacteroides distasonis species Decreases
0 1 Lactobacillus gasseri species Decreases
0 1 Lactobacillus jensenii species Decreases
0 1 Lactobacillus paragasseri species Decreases
0 1 Lactobacillus acidophilus species Decreases
1 0 Agathobacter rectalis species Decreases
1 0 Eggerthella lenta species Decreases
1 0 Streptococcus parasanguinis species Decreases
0 1 Lactobacillus intestinalis species Decreases
1 0 Bacteroides caccae species Decreases
0 1 Lactobacillus crispatus species Decreases
1 0 Bacteroides uniformis species Decreases
0 1 Lactobacillus taiwanensis species Decreases
1 0 Bacteroides ovatus species Decreases
0 1 Lactobacillus iners species Decreases
0 1 Lactobacillus amylovorus species Decreases
0 1 Lactobacillus acetotolerans species Decreases
1 0 Segatella copri species Decreases
0 1 Lactobacillus amylolyticus species Decreases
0 1 Lactobacillus kefiranofaciens species Decreases
1 0 Escherichia coli species Decreases
0 1 Lactobacillus johnsonii species Decreases
1 0 Bifidobacterium longum species Decreases
0 1 Lactobacillus helveticus species Decreases
1 0 Mediterraneibacter gnavus species Decreases
1 0 Clostridioides difficile species Decreases
0 1 Akkermansia glycaniphila species Decreases
0 1 Lactobacillus ultunensis species Decreases
0 1 Lactobacillus casei group species group Decreases
0 1 Bifidobacterium longum subsp. longum subspecies Decreases
0 1 Bifidobacterium longum subsp. infantis subspecies Decreases
0 1 Bifidobacterium longum subsp. suis subspecies Decreases
0 1 Bifidobacterium longum subsp. suillum subspecies Decreases

Impact of fenbendazole,(prescription) on Conditions from US National Library of Medicine

A higher number indicates impact on more bacteria associated with the condition and confidence on the impact.

We have X bacteria high and Y low reported. We find that the modifier reduces some and increases other of these two groups. We just tally: X|reduces + Y|Increase = Positive   X|increases + Y|decrease = Negative.

Benefit Ratio:
Numbers above 0 have increasing positive effect.
Numbers below 0 have increasing negative effect.

Condition Positive Impact Negative Impact Benefit Ratio Impact
Abdominal Aortic Aneurysm 0.6 0.6
Acne 0.6 2 -2.33
ADHD 3.5 1.9 0.84
Age-Related Macular Degeneration and Glaucoma 1.1 0.4 1.75
Allergic Rhinitis (Hay Fever) 2.8 3.1 -0.11
Allergies 5.6 3.2 0.75
Allergy to milk products 1.9 1.6 0.19
Alopecia (Hair Loss) 1 1
Alzheimer's disease 6.4 6.6 -0.03
Amyotrophic lateral sclerosis (ALS) Motor Neuron 4 0.5 7
Ankylosing spondylitis 4.8 2.5 0.92
Anorexia Nervosa 1.8 2.5 -0.39
Antiphospholipid syndrome (APS) 1.6 1.6
Asthma 5.1 3.6 0.42
Atherosclerosis 2.1 1.9 0.11
Atrial fibrillation 3.9 1.9 1.05
Autism 9.4 7.9 0.19
Autoimmune Disease 1.7 1.6 0.06
Barrett esophagus cancer 0.3 -0.3
benign prostatic hyperplasia 0.6 0.3 1
Biofilm 0.6 0.6
Bipolar Disorder 2.9 1.1 1.64
Brain Trauma 0.6 1.6 -1.67
Breast Cancer 0.6 0.6
Cancer (General) 2.1 -2.1
Carcinoma 2.9 1.7 0.71
Celiac Disease 2.5 3.3 -0.32
Cerebral Palsy 1.3 1 0.3
Chronic Fatigue Syndrome 2.1 4.5 -1.14
Chronic Kidney Disease 3 2.8 0.07
Chronic Lyme 0 0.8 0
Chronic Obstructive Pulmonary Disease (COPD) 2.4 1.4 0.71
Chronic Urticaria (Hives) 2.2 1.1 1
Coagulation / Micro clot triggering bacteria 1.4 1 0.4
Cognitive Function 3.2 2 0.6
Colorectal Cancer 7.7 3.3 1.33
Constipation 1.5 0.9 0.67
Coronary artery disease 1.3 2.5 -0.92
COVID-19 7.9 9.4 -0.19
Crohn's Disease 6.4 5.3 0.21
Cushing's Syndrome (hypercortisolism) 0.6 -0.6
cystic fibrosis 1.2 1.6 -0.33
d-lactic acidosis (one form of brain fog) 1 1
deep vein thrombosis 2.4 1.1 1.18
Denture Wearers Oral Shifts 0.9 0.5 0.8
Depression 8.7 9.3 -0.07
Dermatomyositis 0.3 0.3 0
Eczema 1.1 2.3 -1.09
Endometriosis 4 2.6 0.54
Eosinophilic Esophagitis 0.3 -0.3
Epilepsy 3.5 3.5 0
erectile dysfunction 1.1 0.3 2.67
Fibromyalgia 3 2 0.5
Functional constipation / chronic idiopathic constipation 4.3 4.2 0.02
gallstone disease (gsd) 2.7 1.6 0.69
Gastroesophageal reflux disease (Gerd) including Barrett's esophagus 0.8 1.4 -0.75
Generalized anxiety disorder 2.7 2.2 0.23
giant cell arteritis 0.2 -0.2
Glioblastoma 0.3 -0.3
Gout 1 0.7 0.43
Graves' disease 2.8 2.9 -0.04
Gulf War Syndrome 1.4 2.1 -0.5
Halitosis 0.6 0.3 1
Hashimoto's thyroiditis 3.7 2.4 0.54
Heart Failure 3.7 2.4 0.54
hemorrhagic stroke 1 0.5 1
Hidradenitis Suppurativa 0.9 0.9
High Histamine/low DAO 1.9 0.3 5.33
hypercholesterolemia (High Cholesterol) 0.3 0.5 -0.67
hyperglycemia 1.9 2.4 -0.26
Hyperlipidemia (High Blood Fats) 1 1.9 -0.9
hypersomnia 0.3 -0.3
hypertension (High Blood Pressure 5.2 5.1 0.02
Hypothyroidism 0.8 1.5 -0.88
Hypoxia 3.8 0.9 3.22
IgA nephropathy (IgAN) 1.5 3 -1
Inflammatory Bowel Disease 7.3 7.8 -0.07
Insomnia 3.9 2.7 0.44
Intelligence 1 0.1 9
Intracranial aneurysms 0.9 1.1 -0.22
Irritable Bowel Syndrome 7.2 5.5 0.31
ischemic stroke 2.8 1.7 0.65
Juvenile idiopathic arthritis 0.5 0.5
Liver Cirrhosis 7.2 5 0.44
Long COVID 7.3 6.7 0.09
Low bone mineral density 1.1 -1.1
Lung Cancer 0.8 1.2 -0.5
Lymphoma 0.6 0.6
Mast Cell Issues / mastitis 0.9 1.1 -0.22
ME/CFS with IBS 0.5 2.1 -3.2
ME/CFS without IBS 1 1.8 -0.8
membranous nephropathy 0.3 0.3
Menopause 0.8 1.4 -0.75
Metabolic Syndrome 6.7 6.5 0.03
Mood Disorders 9.6 7.8 0.23
multiple chemical sensitivity [MCS] 1.6 0.1 15
Multiple Sclerosis 7.2 7.1 0.01
Multiple system atrophy (MSA) 1.4 0.4 2.5
myasthenia gravis 0.9 0.7 0.29
neuropathic pain 0.3 2.2 -6.33
Neuropathy (all types) 1.5 2.2 -0.47
neuropsychiatric disorders (PANDAS, PANS) 0.4 0.4
Nonalcoholic Fatty Liver Disease (nafld) Nonalcoholic 4.4 4.2 0.05
NonCeliac Gluten Sensitivity 2 1.7 0.18
Obesity 9.4 8.1 0.16
obsessive-compulsive disorder 4.1 3.9 0.05
Osteoarthritis 1.7 1.6 0.06
Osteoporosis 2.4 2.3 0.04
pancreatic cancer 0.3 0.3 0
Parkinson's Disease 8.9 7.6 0.17
Polycystic ovary syndrome 5.7 2.5 1.28
Postural orthostatic tachycardia syndrome 0.2 0.6 -2
Premenstrual dysphoric disorder 0.4 0.4 0
primary biliary cholangitis 1.6 0.6 1.67
Primary sclerosing cholangitis 1.9 1.9 0
Psoriasis 4.9 2.6 0.88
rheumatoid arthritis (RA),Spondyloarthritis (SpA) 7.1 4.3 0.65
Rosacea 1.9 1.5 0.27
Schizophrenia 6 4.4 0.36
scoliosis 0.4 0.5 -0.25
Sjögren syndrome 1.8 3.5 -0.94
Sleep Apnea 2.1 2.6 -0.24
Slow gastric motility / Gastroparesis 0.4 0.8 -1
Small Intestinal Bacterial Overgrowth (SIBO) 1.6 0.1 15
Stress / posttraumatic stress disorder 3.7 4.2 -0.14
Systemic Lupus Erythematosus 4.2 3 0.4
Tic Disorder 0.6 1 -0.67
Tourette syndrome 1.1 0.8 0.38
Type 1 Diabetes 4.2 4 0.05
Type 2 Diabetes 7.9 8.2 -0.04
Ulcerative colitis 6.9 5.5 0.25
Unhealthy Ageing 3.7 2.6 0.42
Vitiligo 2.1 1.7 0.24

Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.

Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription All rights served.   Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 Β§β€―1030, CETS No.185, CFAA   Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license.   Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models.   Inventions /Methodologies on this site are Patent Pending.

Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.216 ]